Authors
Giovanny Vinícius Araújo de França, Evandro de Oliveira Lupatini, Michelle Zanon Pereira, Raisa Breda Tôso Sfalsini, Andréa Leite Ribeiro, Karla Andreia Mette Waldrich, Jaqueline Chueke Pureza, João Paulo Alves Oliveira, Patrícia de Souza Boaventura, Luciana Hentzy Moraes, Meiruze Sousa Freitas, Fernanda De Negri
Published in
Cadernos de saude publica. Volume 42. Pages e00240525. Epub Jul 27, 2026.
Abstract
This study evaluated the Clinical Research Action Plan in Brazil (PAPCB, acronym in Portuguese), established in 2018 by the Brazilian Ministry of Health. This ex post public policy evaluation study was based on documentary analysis for the 2018-2025 period. The six strategic axes of the PAPCB were considered: ethical regulation, sanitary regulation, scientific and technological promotion, training in clinical research, the Clinical Research National Network (RNPC, acronym in Portuguese), and knowledge management. The results showed significant advances in scientific promotion and professional training, with broad execution of the planned actions. The training of more than 45,000 professionals stands out in the training axis. The RNPC underwent restructuring, giving rise to the Brazilian Network of Clinical Research (RBPClin, acronym in Portuguese). However, structural challenges persist, such as the need to modernize Plataforma Brasil, improve knowledge management, and strengthen network collaboration. This study recommends the review and update of the PAPCB, incorporating strategies to overcome these gaps to consolidate the Brazilian scientific, technological, and institutional capacity in clinical research.
PMID:
42524990
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0